Saturday, July 11, 2026

pharma · Amyotrophic Lateral Sclerosis

Wujin People's Hospital

Wujin People's Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Amyotrophic Lateral Sclerosis. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent rec

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Clinical program

Amivita

Unknown · small molecule · Amyotrophic Lateral Sclerosis

Amivita for Amyotrophic Lateral Sclerosis is a Unknown program (small_molecule) at Wujin People's Hospital with 1 ClinicalTrials.gov record(s).

← All Wujin People's Hospital projects Unknown small molecule active

Internal code WJ2017001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Wujin People's Hospital
Phase
Unknown
Modality
small_molecule
Indication
Amyotrophic Lateral Sclerosis
Status
active
Trials
1

Clinical trials